Navigation Links
Hypertension drugs could lower Disability

According to reseasrches, drugs used to treat hypertension could delay muscle loss and disability in seniors. Dr.Graziano Onder, research associate at University of Hopkins has suggested new, beneficial effects of (Angiotensin Converting Enzyme) ACE-inhibitor //drugs, which are widely used for hypertension, beneficial effects on muscle strength and overall physical performance in older adults. This research must be confirmed in future clinical trials.

The Food and Drug Administration has approved such ACE inhibitors as Accupril, Captopril, Altace and Vasotec. The retrospective study at Hokins, published in the medical journal The Lancet, involved analysis of three years of data from 1995 to 1999 on 650 hypertensive and partially disabled women over 60 who participated in the Women's Health and Aging Study, a project of the National Institute on Aging in Bethesda, Md.

The women on continuous ACE inhibitor therapy showed slower loss of walking speed and muscle strength compared to those using other hypertension drugs or using none. During repeated testing over the three-year period, the subjects walking speeds were measured and they were graded on muscle strength.

Correlating that data to pharmaceutical records, the researchers found women on continuous ACE inhibitor therapy had a lower average decline in muscle strength of 2.5 pounds over the three years, as compared to intermittent users of other antihypertensive drugs, at 7.5 pounds and non-users at minus 8.1 pounds.

Continuous ACE inhibitor users had a smaller loss in walking speed -- sixth-tenths of an inch per second compared with intermittent users of ACE inhibitors at 5.3 inches per second, 6.1 inches per second for intermittent users of other antihypertensive drugs and 7 inches per second for non-users.

"If these findings can be confirmed in randomized controlled trials, ACE inhibitors could not only be used as first-line treatment of older adults with h
'"/>




Page: 1 2

Related medicine news :

1. New viewpoint on Hypertension
2. FDA Approves Remodulin for Pulmonary Hypertension
3. Glaucoma & Ocular Hypertension more likely in patients with refractive errors
4. Hypertension lowered by Bedtime Dosing
5. Better Treatment For Hypertension
6. Treating Pulmonary Arterial Hypertension In Children With Viagra
7. Hypertension Drug of Choice for African Americans
8. Hypertension can be caused by Inhalation of Salt
9. Inhaling Salt Can Lead To Hypertension
10. Elderly Women Remain At Risk From Hypertension
11. Elderly Women Remain At Risk From Hypertension

Post Your Comments:
(Date:11/25/2009)...at colorectal cancer also can reverse a rare stoma...erapy for the disease, researchers at Vanderbilt U...ier,s disease causes thickening of the stomach lin...s well as anemia and swelling in the feet and ankl...risk for gastric cancer. Previously, the only effe...
(Date:11/25/2009)...d under the skin kill tumor cells, study finds , ...A cancer vaccine delivered in a fingernail-size im...udy reports. , The method uses polymer disks, 8...umor-specific antigens and implanted under the ski... The Harvard University scientists who developed t...
(Date:11/25/2009)... Nationwide Imaging Services, known as one of...iagnostic imaging equipment, now offering a total ...cing options, service and installation with acquis...echnologies of California) , ...ide Imaging Services is proud to announce its acqu...
(Date:11/25/2009)... BioSpace.com, the premier resource for life ...d edition of the BioForest™ Hotbed Campaign ..., CO (Vocus) November 25, 2009 -- BioSpace.com, th...formation, unveiled the third edition of the BioFo...,This regional campaign is a promotional effort hi...
(Date:11/25/2009)...ethertoShareRecordsSafely,ImproveCare ,, WASH...tofVeteransAffairs(VA)andKaiserPermanentetodayanno...icestoourNation,sheroes.VAandKaiserPermanentearela...rd(EHR)informationusingtheNationwideHealthInformat...umanServices. ,, "Theabilitytosharecriticalheal...
Breaking Medicine News(10 mins):Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2
... was warned about the rising number of Internet ga... Jan Wise, from London at the association's annual... implemented to track down and help addicts. Both ...to 15 year-olds show signs of addiction and 75 % a...
...titute of Health and Welfare (AIHW) it is found th...ber of negligence claims//. A new report show...epartment. Data was collected from 2002 when the m...octors were threatening to quit their jobs. T...
...oiding house dust mite allergens from the time of ...ema or atopy in high-risk children. Furthermore... of fish rich in omega-3 fatty acids was also foun...umption of omega-3 fatty acids, which are found in...
...ould help people lose weight, will be launched in ...ht loss preparation that controls //the desire to ... patients will be the first ones worldwide to have...essing the appetite. It is the first drug of its k...
...ndia by the George Institute for International Hea...dia were at a higher risk of developing lifestyle .... In a developing area of Andhra Pradesh, abou... studies have highlighted the escalating problem o...
...hat the insurance industry is unfair in dealing wi...g denied// travel insurance or are being asked to ...are disease free. A survey conducted by the ...th a pre-existing condition is treated the same. ...
Other Medicine News:Health News:Preventive Measures Proved Ineffective in Allergic Children 2Health News:Wonder Drug For Weight Loss Launched In UK 2Health News:Alarming Rise of Diabetes in Rural India - Survey Reports 2
(Date:11/25/2009)...RNewswire/--TheFDAgrantedtraditionalapprovalforINT...ersetranscriptaseinhibitor(NNRTI).INTELENCEistheon...riencedadultswhoareexperiencingvirologicfailurewit...ral(ARV)agents.Thetraditionalapprovalisbasedon48-w...INTELENCEiscurrentlymarketedintheU.S.byTibotecTher...
(Date:11/25/2009)...Newswire-USNewswire/--RemediumTechnologiesInc.,aco...rebleeding,wonfirstprizeand$10,000intheMostPromisi...2009,companyofficialsannouncetoday. ,, Selected...steampitchedtheirinventionattheGSCSecuritySummitco...edium( www.remediumtechnologies.com )isdevelopinga...
(Date:11/25/2009)...PRNewswire/--RegadoBiosciences,aprivatelyheldcompa...hactivecontrolagents,announcedthatDavidMazzo,PhD,C...stAnnualHealthCareConferenceattheNewYorkPalaceHote...1:10pm(EST)onTuesday,December1andwillincludeanover...elopmentprogram,theanticoagulantsystem,REG1.Thehea...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2New Compact and Folding Reading Glasses from VisAcuity com 3A Never Leave Home Without Them 47465 1New Compact and Folding Reading Glasses from VisAcuity com 3A Never Leave Home Without Them 47465 2Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan 47462 1Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan 47462 2Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan 47462 3Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan 47462 4PLUS Diagnostics First National Laboratory to Offer Highly Specialized Gastrointestinal Tests 47459 1PLUS Diagnostics First National Laboratory to Offer Highly Specialized Gastrointestinal Tests 47459 2
...d at 2008 ICAAC/IDSA Joint Meeting, ROCKVILLE, Md...armaceutical company focused on commercializing,pr...tential, announces the,successful demonstration of... inhibitory concentration (MIC) resulting from in ... candidate, SQ109, and Tibotec,s lead TB,drug cand...
...rmAthene, Inc.,(NYSE ALTERNEXT US: PIP), a biodefe...inst biological and chemical threats, today announ...Phase I clinical trial,evaluating Protexia(R) for ...ch is produced in the milk of transgenic goats, is...ase (BChE), which has been shown to be effective,i...
Other Medicine Technology:Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207 2PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R) 2PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R) 3PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R) 4PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R) 5
Neumann Tying Forceps - Straight
Neumann Tying Forceps - Angled
Shepard Straight Tying Forceps
Shepard Curved Tying Forceps
Medicine Products: